Mutya Harsch, CLO and General Counsel at Foamix Pharmaceuticals Ltd. (FOMX), sold 2,519 shares at $3.75 ($9K) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $9k FOMX by CLO and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |